RxSight, Inc. (RXST) Profit Margins
Over the twelve months to 2026-06-30, RxSight, Inc. (RXST) had operating margin -43.2%, net margin -36.8%, free cash flow margin -21.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RXSTRxSight, Inc.Follow RXST — free
—
Price chart with a free account
- Market cap
- 208.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 9 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 20.0% | 43.5% | 60.4% | 70.7% | 76.6% | — | |
| Operating margin | -233.6% | -129.2% | -56.2% | -26.3% | -35.8% | -43.2% | |
| Net margin | -215.5% | -136.2% | -54.6% | -19.6% | -29.0% | -36.8% | |
| FCF margin | -206.5% | -125.0% | -52.1% | -16.0% | -14.4% | -21.3% |
USD millions · SEC XBRL
RxSight, Inc. — questions
- What is RxSight, Inc.'s operating margin?
- -43.2% over the twelve months to 2026-06-30.
- What is RxSight, Inc.'s net profit margin?
- -36.8% over the twelve months to 2026-06-30.
Every figure on this page comes from RxSight, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.